MedroxyPROGESTERone acetate injectable suspension, USP

150 mg/mL for intramuscular use

Compares To

Depo-Provera®

View Full Prescribing Information, Including Boxed Warning, and Patient Information

Product Features:

  • An estrogen-free birth control
  • Offers effective pregnancy prevention that does not require daily action
  • Requires re-injection every 3 months (13 weeks), or only 4 times a year, at your healthcare provider

Use of medroxyPROGESTERone acetate injectable suspension may cause you to lose calcium stored in your bone and decrease your bone mass. The longer you use medroxyPROGESTERone acetate injectable suspension, the greater your loss of calcium from your bones. Your bones may not recover completely when you stop using medroxyPROGESTERone acetate injectable suspension.

If you use medroxyPROGESTERone acetate injectable suspension continuously for a long time (for more than 2 years), it may increase the risk of weak, porous bones (osteoporosis) that could increase the risk of broken bones, especially after menopause.

You should not use medroxyPROGESTERone acetate injectable suspension for more than 2 years unless you cannot use other birth control methods.

It is not known if your risk of developing osteoporosis is greater if you are a teenager or young adult when you start to use medroxyPROGESTERone acetate injectable suspension.

The most common adverse reactions seen in medroxyPROGESTERone acetate injectable suspension, USP, include irregular vaginal bleeding, weight gain, abdominal pain, headache, weakness, tiredness, nervousness, and dizziness.

MedroxyPROGESTERone acetate injectable suspension does not protect against HIV infection (AIDS) and other sexually transmitted diseases (STDs).

Where to Find
MedroxyPROGESTERone acetate injectable suspension, USP

Find Now



View Additional
Resources

Learn More


View All
Afaxys Pharma
Products

View Now